EV/EBITDA
0.45
+0.01+2.27%
21 min ago
Summary
- As of February 8, 2025, KTTA EV/EBITDA is 0.45, with a rise of +0.01 (+2.27%) during the most recent trading day.
- Over the past year, KTTA EV/EBITDA has dropped by -0.19 (-29.69%).
- KTTA EV/EBITDA is now -96.81% below its all-time high of 14.11.
Performance
KTTA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
KTTA EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +2.3% | -3.2% | -8.4% |
| 1 m1 month | +25.0% | -25.9% | -38.1% |
| 3 m3 months | +25.0% | -26.3% | -49.2% |
| 6 m6 months | +150.0% | -143.5% | -62.0% |
| ytdytd | +25.0% | -26.5% | -38.5% |
| 1 y1 year | -29.7% | +29.1% | -69.7% |
| 5 y5 years | - | - | - |
KTTA EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | 0.36 | +25.0% | |
| 3 m | 3-month | 0.45 | at high | 0.32 | +40.6% |
| 6 m | 6-month | 0.45 | at high | 0.04 | +1025.0% |
| 1 y | 1-year | 0.66 | -31.8% | 0.04 | +1025.0% |
| 3 y | 3-year | 14.11 | -96.8% | 0.04 | +1025.0% |
| 5 y | 5-year | 14.11 | -96.8% | -35.55 | +101.3% |
| alltime | all time | 14.11 | -96.8% | -35.55 | +101.3% |
Pasithea Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 0.45(+25.0%) |
| 2024 | 0.36(-35.7%) |
| Date | Value |
|---|---|
| 2023 | 0.56(-58.2%) |
| 2022 | 1.34(-76.2%) |
| 2021 | 5.64 |
FAQ
- What is Pasithea Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Pasithea Therapeutics?
- What is KTTA EV/EBITDA year-to-date change?
- What is Pasithea Therapeutics EV/EBITDA year-on-year change?
What is Pasithea Therapeutics EV/EBITDA?
The current EV/EBITDA of KTTA is 0.45
What is the all time high EV/EBITDA for Pasithea Therapeutics?
Pasithea Therapeutics all-time high EV/EBITDA is 14.11
What is KTTA EV/EBITDA year-to-date change?
Pasithea Therapeutics EV/EBITDA has changed by +0.09 (+25.00%) since the beginning of the year
What is Pasithea Therapeutics EV/EBITDA year-on-year change?
Over the past year, KTTA EV/EBITDA has changed by -0.19 (-29.69%)